Βιβλιογραφική Τεκμηρίωση:
Validation of an electronic image reader training programme for interpretation of [18F]flutemetamolβ-amyloid PET brain images. Buckley CJ, Sherwin PF, Smith AP, Wolber J, Weick SM, Brooks DJ. Nucl Med Commun. 2017 Mar;38(3):234-241. doi: 10.1097/MNM.0000000000000633.
Diagnostic impact of [18F]flutemetamol PET in early-onset dementia. Zwan MD, Bouwman FH, Konijnenberg E, van der Flier WM, Lammertsma AA, Verhey FR, Aalten P, van Berckel BN, Scheltens P. Alzheimers Res Ther. 2017 Jan 17;9(1):2. doi: 10.1186/s13195-016-0228-4.
Amyloid Positivity Using [18F]Flutemetamol-PET and Cognitive Deficits in Nondemented Community-Dwelling Older Adults. Hammers DB, Atkinson TJ, Dalley BCA, Suhrie KR, Horn KP, Rasmussen KM, Beardmore BE, Burrell LD, Duff K, Hoffman JM. Am J Alzheimers Dis Other Demen. 2017 Sep;32(6):320-328. doi: 10.1177/1533317517698795. Epub 2017 Apr 12.
vizamyl
